Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man
about
Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.Stereoselective ring oxidation of propranolol in man.Stereoselectivity: an issue of significant importance in clinical pharmacology.Enantioselective assays in comparative bioavailability studies of racemic drug formulations: nice to know or need to know?Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique.The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol.Pharmacokinetics and dynamics of penbutolol in humans: evidence for pathway-specific stereoselective clearance.The influence of aging on the stereoselective pharmacokinetics of propranolol in the rat.Stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil: species differences and influence of endotoxin.Evaluation of clinical bradycardiac effect and respiratory adverse effect of β-blocking agents in coronary computed tomography angiography based on theoretical analysis.Input rate-dependent stereoselective pharmacokinetics: enantiomeric oral bioavailability and blood concentration ratios after constant oral input.Drug- or hormone-induced adaptation: model of adrenergic hypersensitivity.
P2860
Q34396966-CADC297D-8DCB-4EF7-91BF-B20356C44A29Q34404301-407BD085-2CAC-4DED-8E0C-6ADED5D30F1CQ34621657-9CF3CD2B-CCD8-46BB-847A-1A1522E64344Q39529348-32B78F97-897F-4C0F-B883-1314B2C267D0Q41113849-57D76A88-995A-452D-B643-D2CB9DA9C26FQ42126042-D8911FCB-79A7-4FD0-BC8E-4D75DEDD13B3Q42532004-2BBA0863-E284-4CB8-B34B-0121FA3AD9E5Q44359528-5A3DEF0E-B966-4BAA-87C9-EE48A83D2D2EQ44405339-58BCCFD6-F42F-483E-BC57-D72D1A7472F5Q49167766-F3406E81-6062-42E1-8627-17E809BCDA59Q51674764-A316A4BD-6BAC-4915-B4E5-BAE5B24F1697Q52411105-CB7E9F16-AC6E-44D8-A6B0-A97B29EEF695Q52425441-327883C2-FB30-4479-9C3A-E899F5AB76C1
P2860
Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man
description
1982 nî lūn-bûn
@nan
1982 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Plasma levels of (+) and (-)-p ...... cemic (+/-)-propranolol in man
@ast
Plasma levels of (+) and (-)-p ...... cemic (+/-)-propranolol in man
@en
Plasma levels of
@nl
type
label
Plasma levels of (+) and (-)-p ...... cemic (+/-)-propranolol in man
@ast
Plasma levels of (+) and (-)-p ...... cemic (+/-)-propranolol in man
@en
Plasma levels of
@nl
prefLabel
Plasma levels of (+) and (-)-p ...... cemic (+/-)-propranolol in man
@ast
Plasma levels of (+) and (-)-p ...... cemic (+/-)-propranolol in man
@en
Plasma levels of
@nl
P2093
P2860
P1476
Plasma levels of (+) and (-)-p ...... cemic (+/-)-propranolol in man
@en
P2093
Hermansson J
Von Bahr C
P2860
P356
10.1111/J.1365-2125.1982.TB04937.X
P407
P577
1982-07-01T00:00:00Z